CG
PRTK

Carlyle Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Carlyle Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,041,131
Closed -$2.3M – 27
2023
Q2 		$2.3M Hold
1,041,131
– – 0.08% 22
2023
Q1 		$2.62M Buy
+1,041,131
New +$2.62M 0.08% 22